Drugs / Vitreosolve
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00664183 | Mar 2008 → Dec 2009 | diabetic retinopathy | Vitreoretinal Technologies, Inc. | Terminated | No outcome recorded Stop: Enrollment |
| Phase 31 trial | ||||||
| Phase 3 | NCT00908778 | Oct 2008 → Jul 2010 | diabetic retinopathy | Vitreoretinal Technologies, Inc. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vitreosolve | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00908778 ↗ |